tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Wave Life Sciences initiated with an Overweight at Cantor Fitzgerald

Cantor Fitzgerald analyst Steve Seedhouse last night initiated coverage of Wave Life Sciences (WVE) with an Overweight rating and $10 price target Wave develops oligonucleotide therapeutics using various mechanistic approaches across diverse indications, the analyst tells investors in a research note. The firm says the company’s emerging preclinical RNA editing programs illustrate power and versatility of its approach.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1